Cargando…
铂类联合多西他赛或长春瑞滨一线治疗晚期非小细胞肺癌的meta分析
BACKGROUND AND OBJECTIVE: Platinum plus a third-generation agent doublet chemotherapy is the standard regimen and first-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC). The aim of this study is to evaluate the efficacy and safety of docetaxel plus platinum (DP) com...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000022/ https://www.ncbi.nlm.nih.gov/pubmed/24758908 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.04.07 |
Ejemplares similares
-
吉西他滨联合长春瑞滨方案一线治疗中国晚期非小细胞肺癌患者的多中心回顾性研究
Publicado: (2012) -
长春瑞滨联合奥沙利铂对比长春瑞滨联合顺铂治疗中晚期非小细胞肺癌的系统评价
Publicado: (2010) -
吉西他滨单药/或联合铂类与紫杉类单药/或联合铂类不同顺序治疗晚期肺鳞癌的疗效与安全性
Publicado: (2015) -
吉西他滨联合奥沙利铂或顺铂一线治疗老年晚期非小细胞肺癌的随机研究
Publicado: (2011) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011)